World Forum on CBFM in Kyoto (October 18-20, 2010) –final program-

pm 0:10-1:10 Lunch Seminar 1 (Ohtsuka Pharma) Chair: Norio Tanahashi (Saitama)
Speakers: Makoto Suematsu (Tokyo) and Shinichiro Uchiyama (Tokyo)

pm 1:30-3:30 Oral session 1 (Modern neuroimaging 1 and Neuroprotection) Chair: Iwao Kanno (Chiba) and Hideaki Hara (Gifu)

1. Iwao Kanno (Chiba, Japan) Brain molecular imaging with PET.
2. Kazuto Masamoto (Chiba, Japan) Optical imaging of live rat cerebral arteries after ischemia.
3. Koji Abe (Okayama, Japan) In vivo optical imaging of apoptosis and autophagy after cerebral ischemia in mice.
4. Hideaki Hara (Gifu, Japan) Ischemia and ER stress.
5. H. Yoshioka, H. Kinouchi & P.H. Chan (Yamanashi, Japan) NADPH oxidase mediates striatal neuronal injury after transient global
   cerebral ischemia.

--- coffee break ---

pm 4:00-6:00 Oral session 2 (Stem cell therapy 1) Chair: Yasuo Katayama (Tokyo) and Shinn-Zong Lin (Taichung)

6. Shinn-Zong Lin (Taichung, Taiwan) Stem cell therapy in chronic stroke patients-Phase II trial.
7. Alexander Kranz (Leipzig, Germany) Transplantation of placenta-derived mesenchymal stromal cells upon experimental stroke in rats.
8. Koji Abe (Okayama, Japan) Transplantation of iPS cells for ischemic mice brain.
9. Ken-ichiro Katsura (Tokyo, Japan) FNK-modified Bcl-2 protects ischemic brain damage.
10. Ling Wei (Atlanta, Georgia) Human stem cell transplantation promote functional recovery after ischemic stroke.

pm 7:00-9:00 Welcome reception with traditional Maiko dancers

am 8:30-9:30 Free poster presentation (Chair: Tatsushi Kamiya, Okayama U.)

am 9:30-12:00 Oral session 3 (Translational stroke research 1) Chair: Christopher Chen (Singapore) and Shinichiro Uchiyama (Tokyo)

11. Christopher Chen (Singapore) “Intracranial stenosis, perfusion and cognitive impairment" be of interest?
12. Seung Hoon Lee (Seoul, Korea) Impact of leptin and adiponectin on hemorrhagic stroke.
13. Shunya Takizawa (Isehara, Japan) A novel inhibitor of plasminogen activator inhibitor-1 provides anti-thrombotic benefits devoid of bleeding effect.
14. Shinichiro Uchiyama (Tokyo, Japan) Mega trials for stroke prevention. 
15. Guo-Yuan Yang (Shanghai, China) Neuroprotection against cerebral ischemia with ARB and modifying signal transduction.

pm 0:10-1:10 Lunch Seminar 2 (Tanabe Mitsubishi Pharma) Chair: Shinichiro Uchiyama (Tokyo)
Speakers: Eng H. Lo (Boston) and Koji Abe (Okayama)

pm 1:30-3:30 Oral session 4 (Stem cell therapy 2) Pak H. Chan (Stanford) and Michael Chopp (Detroit)

16. Eng H. Lo (Boston, USA) Biphasic mechanisms of neurovascular injury and repair in stroke.
17. Michael Chopp (Detroit, USA) Molecular and cellular bases for stimulating brain plasticity using  stem cells.
18. Yan Xu (Pittsburgh, USA) Umbilical cord matrix stem cell therapy after global cerebral ischemia: Evidence of neuronal repair through extracellular signaling.
19. Pak H. Chan (Stanford, USA) Signal transduction and mechanism of ischemic brain damage.

--- coffee break ---

pm 4:00-6:00 Oral session 5 (Translational stroke research 2) Chair: Pierre Amarenco (Paris) and Johannes Boltze (Leipzig)

20. Johannes Boltze (Leipzig, Germany) Autologous cell therapies of ischemic stroke in a large animal model.
21. Norio Tanahashi (Saitama, Japan) prevention of ischemic stroke with anti-hypertension and -platelet therapy.
22. Pierre Amarenco (Paris, France) Beyond LDL lowering, the neuroprotective effect of HDL cholesterol.
23. Shan Ping Yu (Atlanta, USA) Neuroprotective effect of the endogenous neural peptide apelin in neurons.
24. Mikio Shoji (Hirosaki, Japan) Detection and prevention of Alzheimer’s disease.

pm 6:30-7:30 Evening seminar (Pfeizer) Chair: Norio Tanahashi (Saitama), Speaker: Pierre Amarenco (Paris)

pm 7:30-9:30 Meeting party

am 8:30-9:30 Free poster presentation (Chair: Keiko T. Kitazato, Tokushima U.)

am 9:30-12:00 Oral session 6 (Modern neuroimaging 2) Chair: Hidehiro Iida (Osaka) and Jun Hatazawa (Osaka)

25. Ji Hoe Heo (Seoul, Korea) Translational approach to improve thrombolytic efficacy in stroke.
26. Yasuhisa Fujibayashi (Fukui, Japan) Molecular imaging of Cerebrovascular diseases.
27. Jun Hatazawa (Osaka, Japan) PET imaging in patients of acute ischemic stroke.
28. Eku Shimosegawa (Osaka, Japan) Ischemic penumbra analyzed with PET imaging.
29. Hidehiro Iida (Osaka, Japan) Use of PET and SPECT for clinical diagnosis.
30. Nobuo Araki (Saitama, Japan) The role of NO in reducing damages of ischemic stroke.

pm 0:10-1:10 Lunch Seminar 3 (Kyorin Pharma) Chair: Yasuo Katayama (Tokyo)
Speakers: Pak H. Chan (Stanford) and Nobuo Araki (Saitama)

adjourn